Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating the Optimal Drug Therapy in Chronic Kidney Disease Patients With HCV

NCT07770984 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07770984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07770984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating the Optimal Drug Therapy in Chronic Kidney Disease Patients With HCV
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
May 15, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcv infection ( genotype 4) in ckd patients